Artelo Biosciences, Inc. (ARTL)

Artelo Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.6	2.34	2.82	6.89	12.16
Short-Term Investments	-	-	-	1.5	-
Trading Asset Securities	-	-	7.61	9.15	11.95
Cash & Short-Term Investments	0.6	2.34	10.43	17.53	24.11
Cash Growth	-74.34%	-77.58%	-40.53%	-27.29%	1025.72%
Prepaid Expenses	0.1	0.22	0.55	0.79	0.5
Total Current Assets	0.7	2.56	10.98	18.32	24.61
Property, Plant & Equipment	0.06	0.1	0.02	0.06	0.08
Long-Term Investments	-	-	-	-	1.52
Other Intangible Assets	2.04	2.04	2.04	2.04	2.04
Other Long-Term Assets	0	0	0	0	0
Total Assets	2.8	4.7	13.04	20.42	28.25
Accounts Payable	3.04	1.68	1.24	0.91	0.98
Accrued Expenses	0.02	0.06	0.03	0.05	0.02
Short-Term Debt	0.61	-	-	-	-
Current Portion of Leases	0.04	0.04	0.02	0.04	0.03
Other Current Liabilities	0.35	-0	-	-	-
Total Current Liabilities	4.04	1.77	1.29	1	1.03
Long-Term Leases	0.03	0.07	-	0.02	0.06
Total Liabilities	4.07	1.84	1.29	1.02	1.08
Common Stock	0	0	0	0	0
Additional Paid-In Capital	62.01	53.19	52.26	50.68	48.12
Retained Earnings	-63.02	-50.14	-40.31	-31.02	-20.94
Comprehensive Income & Other	-0.27	-0.2	-0.2	-0.25	-0.02
Shareholders' Equity	-1.27	2.86	11.75	19.4	27.17
Total Liabilities & Equity	2.8	4.7	13.04	20.42	28.25
Total Debt	0.68	0.1	0.02	0.06	0.09
Net Cash (Debt)	-0.08	2.23	10.4	17.47	24.03
Net Cash Growth	-	-78.53%	-40.45%	-27.28%	1021.62%
Net Cash Per Share	-0.08	4.16	21.09	37.00	64.64
Filing Date Shares Outstanding	2.12	0.55	0.54	0.48	0.47
Total Common Shares Outstanding	2.02	0.55	0.53	0.48	0.47
Working Capital	-3.35	0.79	9.69	17.32	23.58
Book Value Per Share	-0.63	5.22	22.11	40.77	57.80
Tangible Book Value	-3.31	0.82	9.71	17.36	25.13
Tangible Book Value Per Share	-1.64	1.50	18.27	36.48	53.46

Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q